Graham Capital Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Graham Capital Management's ATRC Position: Q2 2026 in Review
Graham Capital Management sold out of AtriCure (ATRC) in Q2 2026, closing a stake of 9,563 shares — an estimated $273K sold.
Graham Capital Management first reported a position in ATRC in Q4 2022 and held it in 12 quarters. The position peaked at $1.47M in Q1 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Graham Capital Management reported no remaining AtriCure position as of Q2 2026 after selling out during the quarter.
- Graham Capital Management sold 9,563 AtriCure shares in Q2 2026, an estimated $273K.
- Graham Capital Management first reported a position in AtriCure in Q4 2022 and held it in 12 quarters.
- Graham Capital Management's AtriCure position peaked at $1.47M in Q1 2025.
- 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.